我国细胞工程制药的研究现状和发展前景

李刚;刘鹏;刘诚迅;王钊1

引用本文:	李刚;刘鹏;刘诚迅;王钊1.我国细胞工程制药的研究现状和发展前景[J].中国现代应用药学,2002,(4):278-281.
	Li Gang (Li G), Liu Peng (Liu P), Liu Chengxun (Liu CX), Wang Zhao (Wang Z) 1.Present and Prosjecting of Cell Engineering Pharmacy in China[J].Chin J Mod Appl Pharm(中国现代应用药学),2002,(4):278-281.

【打印本页】【HTML】【下载PDF全文】【查看/发表评论】【EndNote】【RefMan】【BibTex】

←前一篇|后一篇→

过刊浏览高级检索

本文已被：浏览 2563次下载 2947次	码上扫一扫！
分享到：微信更多字体:加大+\|默认\|缩小-
我国细胞工程制药的研究现状和发展前景
李刚;刘鹏;刘诚迅;王钊1

作者	单位
李刚;刘鹏;刘诚迅;王钊1

摘要:

关键词: 细胞工程细胞融合核移植染色体改造转基因细胞培养

DOI：

分类号:

基金项目:清华大学·香港浸会大学中药现代化研究联合实验室和清华大学 985计划的支持

Present and Prosjecting of Cell Engineering Pharmacy in China

Li Gang (Li G), Liu Peng (Liu P), Liu Chengxun (Liu CX), Wang Zhao (Wang Z) 1

Abstract:

OBJECTIVE:To review the present and prospecting of cell engineering pharmacy in China.METHOD:According to the recent literatures on this field, animal cell engineering and plant cell engineering pharmacy were summarized and evaluated.RESULTS:Cell engineer

Key words: cell engineering pharmacy, traditional Chinese medicine, transgene, biological reactor